Charisse R. Lillie - 31 Dec 2025 Form 4 Insider Report for EXELON CORP (EXC)

Role: Director
Signature: David T. Skinner, attorney-in-fact for Charisse R Lillie
Issuer symbol: EXC
Transactions as of: 31 Dec 2025
Net transactions value: +$41,238
Form type: 4
Filing time: 02 Jan 2026, 15:07:24 UTC
Previous filing: 01 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lillie Charisse R	Director	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO	David T. Skinner, attorney-in-fact for Charisse R Lillie	02 Jan 2026	0001972789

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXC	Common stock- deferred stock units	Award	$41,238	+940	+8.8%	$43.87	11,579	31 Dec 2025	By Exelon Corp. Directors Deferred Stock Unit Plan	F1
holding	EXC	Common Stock						7,246	31 Dec 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EXC	Deferred phantom share equivalents						3,818	31 Dec 2025	Common Stock	3,818		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Balance includes 96 additional shares acquired through automatic dividend reinvestment.
F2	Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3	Balance includes 34 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.